Ray Dalio Biomarin Pharmaceutical Inc Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 123,656 shares of BMRN stock, worth $7.11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

123,656

Previous 302,480 59.12%

Holding current value

$7.11 Million

Previous $19.9 Million 56.04%

% of portfolio

0.04%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$61.25 - $72.83 $11 Million - $13 Million	-178,824 Reduced 59.12%	123,656 $8.74 Million
Q4 2024 Feb 13, 2025	BUY	$61.93 - $70.49 $9.92 Million - $11.3 Million	160,166 Added 112.54%	302,480 $19.9 Million
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $7.41 Million - $10.1 Million	107,330 Added 306.8%	142,314 $10 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $2.35 Million - $2.92 Million	31,618 Added 939.33%	34,984 $2.88 Million
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $15.7 Million - $18.6 Million	-187,604 Reduced 98.24%	3,366 $293,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $2.25 Million - $2.91 Million	29,576 Added 18.33%	190,970 $18.4 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $971,329 - $1.08 Million	11,418 Added 7.61%	161,394 $14.3 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $2.25 Million - $2.6 Million	25,932 Added 20.91%	149,976 $13 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $1.55 Million - $2.07 Million	17,665 Added 16.61%	124,044 $12.1 Million
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $94,283 - $126,553	-1,165 Reduced 1.08%	106,379 $11 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $5.57 Million - $6.58 Million	67,829 Added 170.79%	107,544 $9.12 Million
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $1.43 Million - $1.74 Million	20,065 Added 102.11%	39,715 $3.29 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $420,944 - $525,274	5,667 Added 40.53%	19,650 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $1,936 - $2,469	-27 Reduced 0.19%	13,983 $1.24 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $685,715 - $783,845	-9,171 Reduced 39.56%	14,010 $1.08 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $735,693 - $826,108	9,743 Added 72.5%	23,181 $1.93 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $1 Million - $1.22 Million	13,438 New	13,438 $1.02 Million

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

184M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.7B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account